Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -98.26% is 57% below its 5-year average of -62.77%, near the low end of its 5-year range (-98.26%–-52.84%).
27.50% below its 12-month average of -77.06%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -23.64%.
RETURN ON ASSETS (ROA)
-98.26%
RETURN ON ASSETS (ROA) AVG TTM
-77.06%
RETURN ON ASSETS (ROA) AVG 3Y
-65.68%
RETURN ON ASSETS (ROA) AVG 5Y
-62.77%
RETURN ON ASSETS (ROA) AVG 10Y
-65.97%
RETURN ON ASSETS (ROA) AVG 15Y
-51.41%
RETURN ON ASSETS (ROA) AVG 20Y
-68.09%
CURRENT VS TTM AVG
-27.50%
CURRENT VS 3Y AVG
-49.60%
CURRENT VS 5Y AVG
-56.54%
CURRENT VS 10Y AVG
-48.95%
CURRENT VS 15Y AVG
-91.12%
CURRENT VS 20Y AVG
-44.31%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-204.78%
vs the sector median at left
Pluri Inc.
Market Cap
$10.59M
Return on Assets (ROA)
-98.26%
TTM Avg
-77.06%
3Y Avg
-65.68%
5Y Avg
-62.77%
Market Cap
$10.59M
Return on Assets (ROA)
-149.72%
TTM Avg
-86.94%
3Y Avg
-66.39%
5Y Avg
-60.64%
Market Cap
$10.56M
Return on Assets (ROA)
-132.59%
TTM Avg
-75.28%
3Y Avg
-65.73%
5Y Avg
-52.31%
Market Cap
$10.41M
Return on Assets (ROA)
N/A
TTM Avg
-37.02%
3Y Avg
-41.41%
5Y Avg
-41.74%
Market Cap
$10.51M
Return on Assets (ROA)
-148.79%
TTM Avg
-109.24%
3Y Avg
-211.74%
5Y Avg
-146.61%
Market Cap
$10.37M
Return on Assets (ROA)
N/A
TTM Avg
-21.71%
3Y Avg
-73.35%
5Y Avg
-116.85%
Market Cap
$10.37M
Return on Assets (ROA)
-52.23%
TTM Avg
-58.24%
3Y Avg
-82.00%
5Y Avg
-104.09%
Market Cap
$10.82M
Return on Assets (ROA)
-404.58%
TTM Avg
-269.82%
3Y Avg
-269.82%
5Y Avg
-269.82%
Market Cap
$10.26M
Return on Assets (ROA)
-88.09%
TTM Avg
-90.94%
3Y Avg
-60.82%
5Y Avg
-50.49%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pluri Inc. (PLUR) | $10.59M | -98.26% | -77.06% | -65.68% | -62.77% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.59M | -149.72% | -86.94% | -66.39% | -60.64% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.56M | -132.59% | -75.28% | -65.73% | -52.31% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.41M | N/A | -37.02% | -41.41% | -41.74% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.51M | -148.79% | -109.24% | -211.74% | -146.61% |
| Polyrizon Ltd. (PLRZ)vs › | $10.37M | N/A | -21.71% | -73.35% | -116.85% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | -52.23% | -58.24% | -82.00% | -104.09% |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -404.58% | -269.82% | -269.82% | -269.82% |
| Lifeward Ltd. (LFWD)vs › | $10.26M | -88.09% | -90.94% | -60.82% | -50.49% |
| Cerenome, Inc. (CNSY)vs › | $11.05M | -185.94% | -166.39% | -133.67% | -110.62% |
ROA
-98.3%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -95.75% |
| 2025-06-30 | -58.38% |
| 2024-06-30 | -52.84% |
| 2023-06-30 | -55.75% |
| 2022-06-30 | -60.59% |
| 2021-06-30 | -53.31% |
| 2020-06-30 | -44.49% |
| 2019-06-30 | -112.77% |
| 2018-06-30 | -67.06% |
| 2017-06-30 | -74.10% |
| 2016-06-30 | -50.60% |
| 2015-06-30 | -36.21% |
| 2014-06-30 | -36.38% |
| 2013-06-30 | -30.97% |
| 2012-06-30 | -31.20% |
| 2011-06-30 | -23.57% |
| 2010-06-30 | -132.57% |
| 2009-06-30 | -148.69% |
| 2008-06-30 | -292.91% |
| 2007-06-30 | -125.30% |
| 2006-06-30 | -71.25% |
| 2005-06-30 | -80.08% |
| 2004-06-30 | -145.95% |
| 2003-06-30 | -46.55% |
| 2002-06-30 | -471.11% |
